Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates

Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $1.16. This compares to loss of $1.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.10%. A quarter ago, it was expected that this drug discovery and development company would post a loss of $0.95 per share when it actually produced a loss of $0.45, delivering a surprise of 52.63%.Over the last fo ...